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General methods. All reactions with air-sensitive materials were carried out under Ar 
using standard Schlenk techniques. TLC was performed using pre-coated silica gel 60 
F254 and developed in the indicated solvent system. Compounds were visualized under 
UV light (λ = 254 nm). Merck 60 (230–400 Mesh) silica gel was used for column 
chromatography. 
1H NMR and 13C NMR spectra were recorded on a 300 MHz spectrometer. Chemical 
shifts are reported in ppm and referenced to the residual non-deuterated solvent 
frequencies (CDCl3: δ 7.26 ppm for 1H, 77.0 ppm for 13C). CP/MAS-13C NMR were 
recorded on a 400 MHz spectrometer Wide Bore (probe: 4 mm MAS WB DVT). The 
sample rotation frequency was 12 kHz and a 2.5 mm ZrO2 rotor was used. Mass spectra 
were recorded by means of MALDI-TOF or FAB/IE techniques. Solids were analysed 
on a diamond plate (ATR) or as films on sodium chloride. 
Powder X-ray diffraction 
Powder X-ray diffraction measurements were carried out with X’PERT MPD with 
conventional Bragg-Brentano geometry using Kα (λ = 1.5406 Å) for values of 2θ from 
2° to 40°.  
Thermogravimetric analysis 
Thermogravimetric analysis was performed on a TGA-Q-50 instrument on a platinum 
plate, heating the samples under nitrogen atmosphere at a heating rate of 10 °C/min.  
UV-visible spectroscopy 
UV-visible spectra data were recorded in a Synergy H4 Hybrid reader using 96 well 
plates.  
Materials 
The following reagents were commercially available and were used as received: 2,5-
dimethoxyterephtaldehyde (DMTA), CuI, o-DCB, n-butanol, NaN3 and DIPEA. 
2,5-dihydroxyterephtaldehyde (DHTA),1 2,5-bis(prop-2-in-1-yloxy)terephtaldehyde 
(BPTA),1 1,3,5-tris-(4-aminophenyl)benzene (TAPB),2 [HC≡C]0.5-TPB-DMTP-COF,1 
were prepared according to reported procedures. 
Adenine, cytosine, uracil and thymine were obtained from Sigma-Aldrich. All the 
compounds were used without further purification.  
Nucleobase interaction studies 
Stock solutions of each nucleobase (3.7 mM) in water were prepared. Each COF (0.5 
mg) was vortexed for 1 min with a solution of each nucleobase at three different 
concentrations (50, 100 and 150 μM). The final volume of each sample was 600 μL. 
Control experiments using the nucleobases were done at the same concentrations. The 
samples were incubated at room temperature for the time indicated in the figures and 
centrifuged at 4 °C for 45 min at 13000 rpm (around 15700 g). The supernatants were 
collected, the absorbance recorded and the amount of free nucleobases quantified 
applying Beer-Lambert law. All the experiments were done in triplicates. Statistical 
analysis was performed using one-way ANOVA Tukey’s test (each group vs Control). 
*P<0.01, **P<0.001, and ***P<0.0001. 
 
Synthesis of the azide-substituted Uracil 
1-azido-3-bromopropane was synthesized following a described 
procedure3b using 1,3-dibromopropane (10.7 mL, 105.4 mmol), NaN3 (7.5 g, 115.4 
mmol) and DMF (150 mL). The crude was purified by column chromatography using 
ciclohexane/AcOEt (10:1) as eluent. 5.0 g of 1-azido-3-bromopropane was obtained as 
a colourless oil (29% yield). 
1H-NMR (300 MHz, CDCl3) δ (ppm) = 3.49 (t, J = 6.4 Hz, 2H, BrCH2CH2CH2N3), 
3.48 (t, J = 6.3 Hz, 2H, BrCH2CH2CH2N3), 2.08 (p, 6.4 Hz, 2H, N1CH2CH2CH2N3). 
 
1-(3-azidoprop-1-yl)-Uracil. Cs2CO3 (9.67 g, 70.0 mmol) was added 
over a suspension of Uracil (10 g, 89.2 mmol) in dry DMF (225 mL). 
The mixture was heated to 40°C. After 30 min, 1-azido-3-
bromopropane (4.2 g, 25.6 mmol) was added and the mixture was heated to 40°C. 
After 24 h, the solvent was removed over low pressure and H2O (200 mL) was added. 
After sonication, the mixture was extracted with a CHCl3/MeOH mixture (10:1, 3x200 
mL). The combined organic phases were dried with MgSO4 and filtered, and the solvent 
was eliminated under low pressure. The crude was purified by column chromatography 
using CHCl3/THF (3:1) as eluent. 1.45 g of UR3N3 was obtained as a white solid (29% 
yield). 
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1H-NMR (300 MHz, CDCl3) δ (ppm) = 9.12 (s, 1H, N3H), 7.17 (d, J = 7.9 Hz, 1H, H6), 
5.72 (d, J = 7.9 Hz, 1H, H5), 3.83 (t, J = 6.8 Hz, 2H, N1CH2CH2CH2N3), 3.41 (t, J = 6.3 
Hz, 2H, N1CH2CH2CH2N3), 1.97 (p, 6.7 Hz, 2H, N1CH2CH2CH2N3). 
13C-NMR (75 MHz, CDCl3) δ (ppm) = 163.5, 150.8, 144.5, 102.4, 48.2, 46.5, 28.0. 
HRMS (FAB): calculated for C7H10N5O2 [M+H]+: 196.0834. Found: 196.0833 [M+H]+. 
 
Synthesis of COFs and characterization  
 
• Synthesis of [HC≡C]0.5-TPB-DMTP-COF:1 
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Scheme S1. Synthesis of [HC≡C]0.5-TPB-DMTP-COF. 
Following the procedure previously described, from DMTA (215.3 mg, 1.109 
mmol), BPTA (268.8 mg, 1.110 mmol), TAPB (520.4 mg, 1.481 mmol) and o-DCB/n-
Butanol (10 mL/10 mL) and acetic acid (6 M, 2.1 mL) in a Pyrex vessel (φ = 29 mm, h 
= 10 cm) were obtained, after Soxhlet extraction in THF, 866.0 mg (94 %) of a yellow 
solid. FTIR (ATR) (cm-1): 3288, 2957, 2127, 1689, 1592, 1504, 1415, 1291, 1208, 
1146, 1036, 878, 829, 694. 
 Figure S1. FTIR (ATR) spectrum of [HC≡C]0.5-TPB-DMTP-COF. 
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Figure S2. PXRD pattern of [HC≡C]0.5-TPB-DMTP-COF. 
 
Table S1. PXRD of [HC≡C]0.5-TPB-DMTP-COF. 
Pos. 
(°2θ) 
d-spacing 
(Å) 
Rel. Int. 
(%) 
FWHM 
(°2θ) 
2.9750 29.698 100 0.3149 
4.9836 17.732 7.81 0.3149 
5.7930 15.256 15.63 0.3542 
7.5515 11.707 7.27 0.3542 
9.8914 8.942 1.64 0.1968 
25.457 3.499 1.21 0.1447 
 
• Synthesis of [Uracil]0.5-TPB-DMTP-COF: 
CuI, DIPEA, DMF, rt
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Scheme S2. Synthesis of [Uracil]0.5-TPB-DMTP-COF. 
To 100.9 mg of [HC≡C]0.5-TPB-DMTP-COF in 2 mL of anhydrous DMF were added 
24.3 mg (0.128 mmol) of CuI and 75 µL of N,N-diisopropylethylamine (DIPEA). The 
suspension was purged with argon for 5 min and then 51 mg (0.261 mmol) of 1-(3-
azidopropyl)uracil were added. The mixture was stirred overnight at room temperature 
under argon and centrifuged at 6000 rpm for 5 min. After washing with DMF, H2O and 
THF the solid was dried under vacuum at 120 ºC yielding an orange powder (151.8 mg, 
quantitative yield). FTIR (ATR) (cm-1): 3026, 2946, 1682, 1618, 1592, 1507, 1455, 
1416, 1373, 1289, 1209, 1145, 1040, 829, 697. 
 Figure S3. FTIR (ATR) spectrum of [Uracil]0.5-TPB-DMTP-COF. 
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Figure S4. PXRD pattern of [Uracil]0.5-TPB-DMTP-COF. 
 
 
Table S2. PXRD of [Uracil]0.5-TPB-DMTP-COF. 
Pos. 
(°2θ) 
d-spacing 
(Å) 
Rel. Int. 
(%) 
FWHM 
(°2θ) 
2.9724 29.724 100 0.2755 
4.9368 17.900 7.85 0.1968 
5.7669 15.325 13.24 0.2755 
7.6366 11.577 3.84 0.3149 
9.8292 8.999 3.37 0.1574 
25.5176 3.491 3.49 0.1574 
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Figure S5. Comparative FTIR (ATR) spectra of [HC≡C]0.5-TPB-DMTP-COF (black), 
[Uracil]0.5-TPB-DMTP-COF (red), and 1-(3-azidopropyl)uracil (blue). 
 
 
• Synthesis of TPB-DMTP-COF:1 
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 Scheme S3. Synthesis of TPB-DMTP-COF. 
DMTA (84.4 mg, 0.435 mmol), TAPB (102.5 mg, 0.292 mmol) and o-DCB/n-
Butanol (2 mL/2 mL) and acetic acid (6 M, 0.4 mL) in a Pyrex vessel (φ = 18 mm, h = 
10 cm) were obtained, after Soxhlet extraction in THF, 162.1 mg (95 %) of a yellow 
solid. FTIR (ATR) (cm-1): 2957, 1592, 1504, 1464, 1410, 1290, 1211, 1144, 1042, 879, 
823, 639. 
 
Figure S6. FTIR (ATR) spectrum of TPB-DMTP-COF. 
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Figure S7. PXRD pattern of TPB-DMTP-COF. 
 
 
Table S3. PXRD of TPB-DMTP-COF. 
Pos. 
(°2θ) 
d-spacing 
(Å) 
Rel. Int. 
(%) 
FWHM 
(°2θ) 
2.9531 29.919 100 0.2362 
4.9972 17.684 11.25 0.2755 
5.7309 15.422 15.95 0.3149 
7.5433 11.720 8.92 0.2755 
9.8263 9.001 2.51 0.1968 
25.5271 3.499 1.03 0.1378 
 
 
 
 
• Synthesis of TPB-DMTP-COF-TAZ:4 
CuI, DIPEA, THF/H2O, rt
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Scheme S4. Synthesis of TPB-DMTP-COF-TAZ. 
34.4 mg (0.18 mmol) of CuI and 129.2 mg of [HC≡C]0.5-TPB-DMTP-COF were 
suspended in a mixture of THF/H2O (3.9/1.7 mL). The suspension was purged with 
Argon for 5 min and then N,N-diisopropylethylamine (DIPEA) was added (92.7 µL). 
The mixture was purged with Argon for 5 min and toluene (0.2 mL) and 60 mg of 1-
azidopropane3 were added. The suspension was stirred overnight at room temperature 
under argon. The solid was centrifuged with 5 mL of THF. Then, it was washed 
thoroughly with water, THF and dried, yielding a yellow solid (166 mg). FTIR (ATR) 
(cm-1): 2965, 2971, 1769, 1591, 1503, 1463, 1414, 1380, 1290, 1146, 1042, 877, 829, 
733, 696, 607. 
 Figure S8. FTIR (ATR) spectrum of TPB-DMTP-COF-TAZ. 
 
 
Figure S9. PXRD patterns of TPB-DMTP-COF-TAZ. 
 
Table S4. PXRD of TPB-DMTP-COF-TAZ. 
Small-angle range Wide-angle range 
Pos. 
(°2θ) 
d-spacing 
(Å) 
Rel. Int. 
(%) 
Pos. 
(°2θ) 
d-spacing 
(Å) 
Rel. Int. 
(%) 
2.7299 32.338 100 5.6783 15.564 100 
5.6243 15.714 9.23 7.4671 11.829 45.80 
   
25.4213 3.504 18.83 
 
Table S5. Lattice parameters of the synthesized COFs. 
 a=b / Å c / Å α=β / º γ / º 
[HC≡C]0.5-TPB-DMTP-COF 35.3 3.50 90 120 
[Uracil]0.5-TPB-DMTP-COF 35.3 3.49 90 120 
TPB-DMTP-COF 35.4 3.49 90 120 
TPB-DMTP-COF-TAZ 36.6 3.50 90 120 
 
 
 
- Nitrogen adsorption isotherms data  
  
Table S6. Surface area, pore volume and pore size of COFs. 
 BET surface area (m2 g-1) 
Pore volume 
(cm3 g-1) 
Pore size 
(nm) 
[HC≡C]0.5-TPB-DMTP-COF (ref 1) 1642 1.02 3.03 
[HC≡C]0.5-TPB-DMTP-COF (this work) 1510 0.94 2.53 
[Uracil]0.5-TPB-DMTP-COF 105 0.088 1.30 
 
TGA of COFs  
 
 
Figure S10. TGA profile of [HC≡C]0.5-TPB-DMTP-COF. 
 
 
 
Figure S11. TGA profile of [Uracil]0.5-TPB-DMTP-COF. 
 Figure S12. TGA profile of TPB-DMTP-COF. 
 
 
 
Figure S13. TGA profile of TPB-DMTP-COF-TAZ. 
 
- 1H NMR, 13C NMR and FTIR spectra of starting materials and COFs  
 
1H NMR 1-(3-azidopropyl)uracil 
 
 
13C NMR 1-(3-azidopropyl)uracil 
 
 FTIR 1-(3-azidopropyl)uracil 
 
 
 
 
 
Figure S14. CP/MAS-13C NMR of [HC≡C]0.5-TPB-DMTP-COF. 
  
Figure S15. CP/MAS-13C NMR of [Uracil]0.5-TPB-DMTP-COF. 
 
 
Figure S16. CP/MAS-13C NMR of TPB-DMTP-COF-TAZ. 
 - Elemental Analysis 
 
• [HC≡C]0.5-TPB-DMTP-COF 
Calculated - C: 80.75 %, H: 4.84 %, N: 6.73 % 
Experimental - C: 78.73 %, H: 5.06 %, N: 6.46 % 
Experimental - C: 79.20 %, H: 4.99 %, N: 6.48 % 
Experimental - C: 79.04 %, H: 5.05 %, N: 6.47 % 
 
• [Uracil]0.5-TPB-DMTP-COF 
Calculated – C: 68.73 %, H: 4.78 %, N: 16.03 % 
Experimental – C: 60,91 %, H: 4,72 %, N: 13,71 % 
Experimental – C: 61,50 %, H: 4,80 %, N: 14,00 % 
Experimental – C: 61,39 %, H: 4,76 %, N: 13,78 % 
 
• TPB-DMTP-COF 
Calculated - C: 79.57 %, H: 5.14 %, N: 7.14 % 
Experimental - C: 78.38 %, H: 5.67 %, N: 6.06 % 
Experimental - C: 75.56 %, H: 5.43 %, N: 5.83 % 
Experimental - C: 78.36 %, H: 5.69 %, N: 6.12 % 
 
• TPB-DMTP-COF-TAZ 
Calculated - C: 73.60 %, H: 5.56 %, N: 14.31 % 
Experimental - C: 64.14 %, H: 4.99 %, N: 10.24 % 
Experimental - C: 64.58 %, H: 5.00 %, N: 10.27 % 
Experimental - C: 64.10 %, H: 4.91 %, N: 10.13 % 
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Figure S17. Concentration of nucleobases in the media after incubation at 150 µM using 
TPB-DMTP-COF-TAZ (COF-P) and [Uracil]0.5-TPB-DMTP-COF (COF-U) for 22 
hours. (a) Adenine, (b) Cytosine. The interaction of adenine with [Uracil]0.5-TPB-
DMTP-COF is superior compared with any other combination. All the experiments 
were done in triplicates. Statistical analysis was performed using one-way ANOVA 
Tukey’s test (each group vs Control). *P<0.01, **P<0.001, and ***P<0.0001. 
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